Related Experiment Videos

Impact of low-dose chest computed tomography and multiplex PCR on antibiotic usage for community-acquired pneumonia:

L Zhang1, R M Aleva2, H S M Ammerlaan3

  • 1Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.

Abstract

Insights

Low-dose chest CT did not significantly reduce broad-spectrum antibiotic use in community-acquired pneumonia (CAP) patients. Multiplex Point-of-Care PCR (PoC-PCR) showed potential but requires further investigation for antibiotic treatment impact.

Area of Science:

  • Infectious Diseases
  • Radiology
  • Medical Diagnostics

Background:

  • Community-acquired pneumonia (CAP) management often involves broad-spectrum antibiotics.
  • Optimizing diagnostic strategies is crucial to reduce antibiotic overuse and resistance.
  • Novel diagnostic tools like low-dose CT and PoC-PCR are being explored for CAP.

Purpose of the Study:

  • To evaluate if low-dose chest computed tomography (CT) or multiplex Point-of-Care PCR (PoC-PCR) can reduce broad-spectrum antibiotic use in moderate-severe CAP.
  • To assess the impact of these diagnostic methods on antibiotic treatment duration and patient mortality.

Main Methods:

  • A multicentre prospective controlled before-after study with cluster randomisation was conducted in the Netherlands.
  • Adult CAP patients received either low-dose CT, PoC-PCR, or standard care, with antibiotic treatment recommendations provided.
  • The study compared days on broad-spectrum antibiotic therapy (DOT) and 90-day all-cause mortality.

Main Results:

  • Low-dose CT did not demonstrate non-inferiority in reducing DOT for broad-spectrum antibiotics compared to standard care.
  • PoC-PCR showed non-inferiority for DOT, with an adjusted relative risk of 0.89 (95% CI 0.75 to 1.04).
  • The study was prematurely terminated due to COVID-19 pandemic-related changes in diagnostic practices.

Conclusions:

  • Low-dose chest CT is unlikely to significantly impact broad-spectrum antibiotic treatment in moderate-severe CAP.
  • A relevant effect of PoC-PCR on antibiotic treatment could not be definitively demonstrated or excluded.
  • Further research is needed to clarify the role of PoC-PCR in optimizing antibiotic use for CAP.